Immunohistochemistry (IHC) Market Size to Reach $3.1 Billion by 2025: Grand View Research, Inc.

Tuesday, April 11, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, April 11, 2017 /PRNewswire/ --

The global immunohistochemistry (IHC) market is

estimated to reach a value of USD 3.1 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are
recognized to be the most influential factors driving the growth of the immunohistochemistry market. Furthermore, the rapid growth of biotech industry highlighted by increase in growth and revenue coupled with increase in stock market capitalization will nurture the growth.

     (Logo: )

Cancer has high morbidity and mortality risk associated with them. The diagnosis of the disease is majorly dependent on the stage of the disease at admission. This has led to the high demand of immunohistochemistry products. IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning the treatment for the disease, creating a demand for immunohistochemistry products. In addition, the rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and the increasing approvals of the same by the FDA to treat specific types of cancer are expected to benefit the growth in the long run.

Other important factors driving growth include the alarming rise in healthcare spending and the shift in focus on value-based healthcare solutions. In 2015, the U.S. healthcare spending witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the issue and establish a more value-based healthcare delivery, hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes.

Browse full research report with TOC on "Immunohistochemistry (IHC) Market Analysis By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Drug Testing), By End-Use (Hospitals, Diagnostic Laboratories, Research Institutes), And Segment Forecasts, 2014 - 2025" at:

Further key findings from the report suggest: 

  • North America registered the largest growth rate in the immunohistochemistry market in 2016
  • The APAC region is expected to witness the fastest growth owing to increasing healthcare expenses driven by expanding aging population offering significant growth opportunities for players
  • The hospitals and diagnostic laboratories segment accounted for the largest share of the immunohistochemistry market, by end-use due to the growing application of immunohistochemistry products for diagnostic procedures
  • The antibody segment accounted for the largest share of immunohistochemistry market due to the increase in approvals by regulatory bodies for therapeutic antibody products
  • Key players mapped in the report include Abcam plc, Agilent Technologies, BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck Millipore, PerkinElmer Inc., and Thermo Fisher Scientific Inc.

Browse related reports by Grand View Research: 

  • Biological Seed Treatment Market -
  • Biomaterials Market -
  • Expression Vectors Market -
  • Cholera Vaccines Market -

Grand View Research has segmented the immunohistochemistry market on the basis of product, application, and end-use: 

  • Product Outlook (Revenue, USD Million; 2014 - 2025) 
    • Antibodies
      • Primary antibodies
      • Secondary antibodies
    • Equipment
      • Slide staining systems
      • Tissue microarrays
      • Tissue processing systems
      • Slide scanners
      • Others
    • Reagents
      • Histological stains
      • Blocking sera and reagents
      • Chromogenic substrates
      • Fixation reagents
      • Stabilizers
      • Organic solvents
      • Proteolytic enzymes
      • Diluents
    • Kits
  • Application Outlook (Revenue, USD Million; 2014 - 2025) 
    • Diagnostics
      • Cancer
      • Infectious diseases
      • Cardiovascular diseases
      • Autoimmune diseases
      • Diabetes mellitus
      • Nephrological diseases
    • Drug Testing
  • End- Use Outlook (Revenue, USD Million; 2014 - 2025) 
    • Hospitals and diagnostic laboratories
    • Research institutes
    • Others
  • Regional Outlook (Revenue, USD Million; 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Read Our Blog: Rising incidence of cancer is expected to lead the immunohistochemistry market

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store